Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison-Lessons for Future Studies

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Greve, Burkhard ^a   Bölling, Tobias ^a   Amler, Susanne ^d   Rössler, Ute ^f   Gomolka, Maria ^f   Mayer, Claudia ^e   Popanda, Odilia ^e   Dreffke, Kristin ^b,g   Rickinger, Astrid ^c   Fritz, Eberhard ^b,h   Eckardt Schupp, Friederike ^c   Sauerland, Christina ^d   Braselmann, Herbert ^c   Sauter, Wiebke ^c   Illig, Thomas ^c   Riesenbeck, Dorothea ^a,i   Könemann, Stefan ^a,j   Willich, Normann ^a   Mörtl, Simone ^c   Eich, Hans Theodor ^a   Schmezer, Peter ^e   more..

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h MAX PLANCK INSTITUTE FOR BIOGEOCHEMISTRY   (Germany)

ⁱ Practice of Radiotherapy   (Germany)

^j Centre for Radiotherapy   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HISTONE H2AX; LIPOCORTIN 5;

ACUTE TOXICITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL ASSAY; CELL DEATH; CELL IMMORTALIZATION; COMET ASSAY; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; LYMPHOBLASTOID CELL LINE; MARKER GENE; PERIPHERAL LYMPHOCYTE; PREDICTION; PROTEIN PHOSPHORYLATION; RADIATION RESPONSE; RADIOSENSITIVITY;

BIOLOGICAL MARKERS; CELLS, CULTURED; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; HISTONES; HUMANS; LYMPHOCYTES; RADIATION TOLERANCE; RADIATION, IONIZING;

EID: 84867886900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047185     Document Type: Article

References (55)

1. Baumann M (1995) Impact of endogenous and exogenous factors on radiation sequelae. In Dunst J, Suaer R, editors. Late sequelae in oncology. Medical radiology, diagnostic imaging and radiation oncology. Heidelberg: Springer Verlag.
2. Bese NS, Hendry J, Jeremic B, (2007) Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 68: 654-661.
3. Tucker SL, Geara FB, Peters LJ, Brock WA, (1996) How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother Oncol 38: 103-113.
4. BMU (2008) Schriftenreihe Strahlenschutz und Reaktorsicherheit. Available: http://wwwbmude/mediathek/veroeffentlichungen/schriftenreihe/doc/20112php: Accessed 2012 Sep 14.
5. Twardella D, Chang-Claude J, (2002) Studies on radiosensitivity from an epidemiological point of view - overview of methods and results. Radiother Oncol 62: 249-260.
6. Fernet M, Hall J, (2008) Predictive markers for normal tissue reactions: fantasy or reality? Cancer Radiother 12: 614-618.
7. Dikomey E, Borgmann K, Peacock J, Jung H, (2003) Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56: 1194-1200.
8. Riesenbeck D (2005) Multiparametrische Untersuchungen an Strahlentherapiepatienten mit auffälligen Strahlenreaktionen. Available: http://www.bmu.de/files/strahlenschutz/schriftenreihe_reaktorsicherheit_strahlenschutz/application/pdf/schriftenreihe_rs662.pdf. Accessed 2012 Sep 14.
9. Perez CA, Bracy LW (1993) Acute radiation morbidity scoring criteria (RTOG). In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology, 2nd ed. Philadelphia: Lippincott. 53-55.
10. NCI (1988) Common toxicity criteria. Bethesda, MD: Devision of Cancer Treatment, National Cancer Institute.
11. Seegenschmiedt MH (1998) Nebenwirkungen in der Onkologie. Internationale Systematik und Dokumentation. Heidelberg: Springer.
12. Greve B, Dreffke K, Rickinger A, Konemann S, Fritz E, et al. (2009) Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity. Apoptosis 14: 226-235.
13. Severin E, Greve B, Pascher E, Wedemeyer N, Hacker-Klom U, et al. (2006) Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. Int J Radiat Oncol Biol Phys 64: 242-250.
14. Rosenberger A, Rossler U, Hornhardt S, Sauter W, Bickeboller H, et al. (2011) Validation of a fully automated COMET assay: 1.75 million single cells measured over a 5 year period. DNA Repair (Amst) 10: 322-337.
15. Schunck C, Johannes T, Varga D, Lorch T, Plesch A, (2004) New developments in automated cytogenetic imaging: unattended scoring of dicentric chromosomes, micronuclei, single cell gel electrophoresis, and fluorescence signals. Cytogenet Genome Res 104: 383-389.
16. Lobrich M, Ikpeme S, Kiefer J, (1994) DNA double-strand break measurement in mammalian cells by pulsed-field gel electrophoresis: an approach using restriction enzymes and gene probing. Int J Radiat Biol 65: 623-630.
17. Wistop A, Keller U, Sprung CN, Grabenbauer GG, Sauer R, et al. (2005) Individual radiosensitivity does not correlate with radiation-induced apoptosis in lymphoblastoid cell lines or CD3+ lymphocytes. Strahlenther Onkol 181: 326-335.
18. Williams JR, Zhang Y, Zhou H, Russell J, Gridley DS, et al. (2008) Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution. Int J Radiat Biol 84: 151-164.
19. Crompton NE, Miralbell R, Rutz HP, Ersoy F, Sanal O, et al. (1999) Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys 45: 707-714.
20. Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, et al. (2001) Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 49: 547-554.
21. Bordon E, Henriquez-Hernandez LA, Lara PC, Ruiz A, Pinar B, et al. (2010) Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs). Radiat Oncol 5: 4.
22. Azria D, Betz M, Bourgier C, Sozzi WJ, Ozsahin M (2010) Identifying patients at risk for late radiation-induced toxicity. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2010.08.003.
23. Mayer C, Popanda O, Greve B, Fritz E, Illig T, et al. (2011) A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects. Cancer Lett 302: 20-28.
24. Cohen JI, (2000) Epstein-Barr virus infection. N Engl J Med 343: 481-492.
25. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, et al. (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90: 8479-8483.
26. Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, et al. (2004) EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol 78: 12694-12697.
27. Zou P, Kawada J, Pesnicak L, Cohen JI, (2007) Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. J Virol 81: 10029-10036.
28. Rube CE, Fricke A, Wendorf J, Stutzel A, Kuhne M, et al. (2010) Accumulation of DNA double-strand breaks in normal tissues after fractionated irradiation. Int J Radiat Oncol Biol Phys 76: 1206-1213.
29. Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, et al. (2003) Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys 55: 1216-1225.
30. Rzeszowska-Wolny J, Palyvoda O, Polanska J, Wygoda A, Hancock R, (2008) Relationships between acute reactions to radiotherapy in head and neck cancer patients and parameters of radiation-induced DNA damage and repair in their lymphocytes. Int J Radiat Biol 84: 635-642.
31. Alapetite C, Thirion P, de la Rochefordiere A, Cosset JM, Moustacchi E, (1999) Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 83: 83-90.
32. Vasireddy RS, Sprung CN, Cempaka NL, Chao M, McKay MJ, (2010) H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotype. Br J Cancer 102: 1511-1518.
33. Rube CE, Grudzenski S, Kuhne M, Dong X, Rief N, et al. (2008) DNA double-strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: implications for radiosensitivity testing. Clin Cancer Res 14: 6546-6555.
34. Taneja N, Davis M, Choy JS, Beckett MA, Singh R, et al. (2004) Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279: 2273-2280.
35. Banath JP, Macphail SH, Olive PL, (2004) Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 64: 7144-7149.
36. Klokov D, MacPhail SM, Banath JP, Byrne JP, Olive PL, (2006) Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol 80: 223-229.
37. Mirzayans R, Severin D, Murray D, (2006) Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity. Int J Radiat Oncol Biol Phys 66: 1498-1505.
38. Lobrich M, Rief N, Kuhne M, Heckmann M, Fleckenstein J, et al. (2005) In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci U S A 102: 8984-8989.
39. Bergqvist M, Brattstrom D, Stalberg M, Vaghef H, Brodin O, et al. (1998) Evaluation of radiation-induced DNA damage and DNA repair in human lung cancer cell lines with different radiosensitivity using alkaline and neutral single cell gel electrophoresis. Cancer Lett 133: 9-18.
40. Marples B, Longhurst D, Eastham AM, West CM, (1998) The ratio of initial/residual DNA damage predicts intrinsic radiosensitivity in seven cervix carcinoma cell lines. Br J Cancer 77: 1108-1114.
41. Rajeswari N, Ahuja YR, Malini U, Chandrashekar S, Balakrishna N, et al. (2000) Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis 21: 557-561.
42. Shahidi M, Mozdarani H, Bryant PE, (2007) Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay. Cancer Lett 257: 263-273.
43. Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N, (2010) Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res 173: 505-511.
44. Werbrouck J, De Ruyck K, Beels L, Vral A, Van Eijkeren M, et al. (2010) Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity. Oncol Rep 23: 571-578.
45. Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, et al. (2003) Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol 69: 145-153.
46. Djuzenova CS, Muhl B, Fehn M, Oppitz U, Muller B, et al. (2006) Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays. Br J Cancer 94: 1194-1203.
47. Hamasaki K, Imai K, Nakachi K, Takahashi N, Kodama Y, et al. (2007) Short-term culture and gammaH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes. Environ Mol Mutagen 48: 38-47.
48. Olive PL, Banath JP, Keyes M, (2008) Residual gammaH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy. Radiother Oncol 86: 336-346.
49. Andrievski A, Wilkins RC, (2009) The response of gamma-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures. Int J Radiat Biol 85: 369-376.
50. McManus KJ, Hendzel MJ, (2005) ATM-dependent DNA damage-independent mitotic phosphorylation of H2AX in normally growing mammalian cells. Mol Biol Cell 16: 5013-5025.
51. Zijno A, Porcedda P, Saini F, Allione A, Garofalo B, et al. (2010) Unsuitability of lymphoblastoid cell lines as surrogate of cryopreserved isolated lymphocytes for the analysis of DNA double-strand break repair activity. Mutat Res 684: 98-105.
52. Starmans MH, Fung G, Steck H, Wouters BG, Lambin P, (2011) A simple but highly effective approach to evaluate the prognostic performance of gene expression signatures. PLoS One 6: e28320.
53. Sonis S, Haddad R, Posner M, Watkins B, Fey E, et al. (2007) Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol 43: 289-300.
54. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, Franken NA, Haveman J, et al. (2006) Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 3: e422.
55. Henriquez Hernandez LA, Lara PC, Pinar B, Bordon E, Rodriguez Gallego C, et al. (2009) Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiat Oncol 4: 17.